Tag: Biotechnology company

Browse exclusive Tags!

MTx Secures Funding for AntiBKV, a Promising Treatment for BK Polyomavirus Infection in Kidney Transplants

MTx secures funding for development of AntiBKV, a potential treatment for BK Polyomavirus infection in kidney transplant recipients.

Generation Bio Unveils IQDNA: A Revolutionary Advancement in Genetic Medicines

Discover Generation Bio's groundbreaking advancement in genetic medicine with their proprietary immune-quiet DNA (iqDNA). Promising results in preclinical studies.

Gilead Sciences and Assembly Biosciences Partner to Advance Antiviral Therapeutics

Gilead Sciences and Assembly Biosciences collaborate to develop novel antiviral therapies, targeting serious viral diseases. A promising partnership.

Nkarta Receives FDA Clearance for CAR NK Cell Therapy Trial in Severe Lupus Nephritis, US

Get the latest news on Nkarta's groundbreaking FDA-approved CAR NK cell therapy trial for lupus nephritis. Promising treatment option for refractory LN patients.

Popular

Nkarta Receives FDA Clearance for CAR NK Cell Therapy Trial in Severe Lupus Nephritis, US

Get the latest news on Nkarta's groundbreaking FDA-approved CAR NK cell therapy trial for lupus nephritis. Promising treatment option for refractory LN patients.

Novavax Q2 Earnings Soar, Exceed Analyst Expectations

Novavax's Q2 earnings surpass projections with successful Covid vaccine development & distribution, promising future ahead.

Alterity Therapeutics Receives A$4.74M Cash Refund for Research and Development, Advancing Clinical Trials for ATH434, Australia

Alterity Therapeutics receives A$4.74M cash refund for research, further advancing neurodegenerative disease treatments.

ABVC BioPharma Soars 100% on Exclusive Psychiatric Drug Deal in China

ABVC BioPharma's stock surges after licensing deal: Chinese market exclusive rights for psychiatric drug candidates. Caution advised for investors.

Subscribe

spot_imgspot_img